Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library ... Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library comprised of approximately 1,500 bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its product ATR-12 is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its product ATR-04 is a genetically modified strain of S. epidermidis for treating the papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease. Mehr anzeigen
Azitra, Inc. to Present at The Microcap Conference PR Newswire BRANFORD, Conn., Jan. 27, 2025 BRANFORD, Conn., Jan. 27, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage...
Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock PR Newswire BRANFORD, Conn., Jan. 15, 2025 BRANFORD, Conn., Jan. 15, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American:...
Azitra Announces Proposed Public Offering of Common Stock PR Newswire BRANFORD, Conn., Jan. 14, 2025 BRANFORD, Conn., Jan. 14, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a...
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates PR Newswire BRANFORD, Conn., Nov. 12, 2024 BRANFORD, Conn., Nov. 12, 2024 /PRNewswire/ -- Azitra, Inc. (NYSE...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0013 | 0.529747351263 | 0.2454 | 0.3515 | 0.2325 | 5021773 | 0.28544067 | CS |
| 4 | -0.2057 | -45.4686118479 | 0.4524 | 0.65 | 0.2325 | 4923384 | 0.41132706 | CS |
| 12 | -0.2441 | -49.7351263244 | 0.4908 | 0.65 | 0.2325 | 1703509 | 0.41561984 | CS |
| 26 | -0.5323 | -68.3311938383 | 0.779 | 0.978 | 0.2325 | 1406528 | 0.53026452 | CS |
| 52 | -38.4533 | -99.3625322997 | 38.7 | 38.7 | 0.2325 | 1726021 | 3.31855609 | CS |
| 156 | -127.5533 | -99.8069640063 | 127.8 | 155.4 | 0.2325 | 1074756 | 3.97405017 | CS |
| 260 | -127.5533 | -99.8069640063 | 127.8 | 155.4 | 0.2325 | 1074756 | 3.97405017 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 27,02 (-0,48%) | 102,26M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 5,82 (1,39%) | 81,08M |
| TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2,3017 (-2,26%) | 75,06M |
| NVDQT Rex 2X Inverse NVIDIA Daily Target ETF | US$ 3,565 (7,70%) | 70,47M |
| SOXSDirexion Daily Semiconductor Bear 3X Shares New | US$ 20,61 (0,73%) | 67,19M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
